These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial. Hayakawa S; Matsuzawa Y; Irie T; Rikitake H; Okada N; Suzuki Y Multidiscip Respir Med; 2016; 11():38. PubMed ID: 27826444 [TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study. Yamazoe M; Tomioka H BMJ Open Respir Res; 2018; 5(1):e000342. PubMed ID: 30397488 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study. Isshiki T; Sakamoto S; Kinoshita A; Sugino K; Kurosaki A; Homma S Respiration; 2015; 89(3):201-7. PubMed ID: 25659984 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Wang B; Li T Exp Ther Med; 2020 Jul; 20(1):351-358. PubMed ID: 32537001 [TBL] [Abstract][Full Text] [Related]
13. Acute Exacerbation in Interstitial Lung Disease. Leuschner G; Behr J Front Med (Lausanne); 2017; 4():176. PubMed ID: 29109947 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Isshiki T; Sakamoto S; Homma S Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31137593 [TBL] [Abstract][Full Text] [Related]
16. Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report. Hirai K; Homma T; Yamaguchi F; Yamaguchi M; Suzuki S; Tanaka A; Ohnishi T; Sagara H BMC Pulm Med; 2019 Jan; 19(1):15. PubMed ID: 30642317 [TBL] [Abstract][Full Text] [Related]
17. Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis. Spagnolo P; Wuyts W Curr Opin Pulm Med; 2017 Sep; 23(5):411-417. PubMed ID: 28582317 [TBL] [Abstract][Full Text] [Related]
18. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study. Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051 [TBL] [Abstract][Full Text] [Related]
19. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP). Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235 [TBL] [Abstract][Full Text] [Related]
20. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation. Richeldi L Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]